Health policy news

EMA push towards transparency

Added: Thursday 7 February 2013

The executive director of the European Medicines Agency has confirmed that the Agency is committed to greater transparency about data. The Agency is now working towards proactive publication of clinical trial data. It is currently consulting on policy, with advisory groups working on five key areas.